The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
Brandon J. Perumpail(St. Christopher's Hospital for Children), Donghee Kim(Chungnam National University), Karn Wijarnpreecha(University of Arizona), Richie Manikat(Stanford University), George Cholankeril(Baylor College of Medicine), Aijaz Ahmed(Stanford University)
Cited by 25
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonobese Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2016|346
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
|World Journal of Hepatology|2017|183
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56
Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
|World Journal of Gastroenterology|2021|41